Research output per year
Research output per year
Personal profile
Public Profile
Dr Centenera is a Research Fellow in the Prostate Cancer Research Group located at the South Australian Health and Medical Research Institute. Her research is focused on improving treatments for men with prostate cancer. This involves understanding and targeting the androgen receptor in prostate cancer cells, and identifying more accurate markers for monitoring patient response to current and emerging prostate cancer therapeutics. Dr Centenera is an expert in patient-derived explants as a preclinical model of prostate cancer.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Rahman, R., Rahaman, M. H., Hanson, A. R., Choo, N., Xie, J., Townley, S. L., Shrestha, R., Hassankhani, R., Islam, S., Ramm, S., Simpson, K. J., Risbridger, G. P., Best, G., Centenera, M. M., Balk, S. P., Kichenadasse, G., Taylor, R. A., Butler, L. M., Tilley, W. D. & Conn, S. J. & 3 others, , 2024, (Accepted/In press) In: British Journal of Cancer.Research output: Contribution to journal › Article › peer-review
Open Access -
Circulating Lipid Profiles Associated with Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer
Lin, H. M., Yang, X., Centenera, M. M., Huynh, K., Giles, C., Dehairs, J., Swinnen, J. V., Hoy, A. J., Meikle, P. J., Butler, L. M., Taplin, M. E. & Horvath, L. G., 1 Jul 2024, In: JCO Precision Oncology. 8, e2400260.Research output: Contribution to journal › Article › peer-review
-
A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer
Shin, S. Y., Centenera, M. M., Hodgson, J. T., Nguyen, E. V., Butler, L. M., Daly, R. J. & Nguyen, L. K., 19 Jan 2023, In: Frontiers in Molecular Biosciences. 10, 1094321.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
Hinneh, J. A., Gillis, J. L., Mah, C. Y., Irani, S., Shrestha, R. K., Ryan, N. K., Atsushi, E., Nassar, Z. D., Lynn, D. J., Selth, L. A., Kato, M., Centenera, M. M. & Butler, L. M., 12 Oct 2023, In: British Journal of Cancer. 129, 8, p. 1350-1361 12 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants
Centenera, M. M., Vincent, A. D., Moldovan, M., Lin, H. M., Lynn, D. J., Horvath, L. G. & Butler, L. M., 1 Apr 2022, In: Cancers. 14, 7, 1708.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus)